In this study that included 92 patients with mCRPC treated with [177Lu]Lu-PSMA I&T, baseline laboratory values (CRP, LDH, and AST) and intervalDiagnosis-RLT (reflecting a possible indicator for tumor aggressiveness) were independent predictors of survival during long-term follow-up. This evidence concerns the gene FOLH1 and neoplasm.